Tarras Defense secured a significant sentencing result this week in a major federal healthcare fraud prosecution involving allegations tied to cancer genetic testing and more than $124 million in intended loss.
Founding attorney David Tarras represented the client for nearly seven years through multiple federal investigations, parallel proceedings, and indictments in two separate federal districts. The government identified the client as the number two participant in the alleged conspiracy and sought a sentence driven by an advisory guideline range of 151 months.